60 Day FRN

B. Published 60-day NDSP.pdf

National Disease Surveillance Program

60 Day FRN

OMB: 0920-0009

Document [pdf]
Download: pdf | pdf
Federal Register / Vol. 87, No. 99 / Monday, May 23, 2022 / Notices
Atlanta, Georgia 30309. Comments can
also be sent electronically to
[email protected]:
1. Heart of Georgia Bancshares, Inc.,
Vidalia, Georgia; to acquire Bank of
Lumber, Lumber City, Georgia.
Board of Governors of the Federal Reserve
System.
Michele Taylor Fennell,
Deputy Associate Secretary of the Board.
[FR Doc. 2022–11008 Filed 5–20–22; 8:45 am]
BILLING CODE 6210–01–P

Board of Governors of the Federal Reserve
System.
Michele Taylor Fennell,
Deputy Associate Secretary of the Board.

FEDERAL RESERVE SYSTEM

lotter on DSK11XQN23PROD with NOTICES1

Formations of, Acquisitions by, and
Mergers of Bank Holding Companies
The companies listed in this notice
have applied to the Board for approval,
pursuant to the Bank Holding Company
Act of 1956 (12 U.S.C. 1841 et seq.)
(BHC Act), Regulation Y (12 CFR part
225), and all other applicable statutes
and regulations to become a bank
holding company and/or to acquire the
assets or the ownership of, control of, or
the power to vote shares of a bank or
bank holding company and all of the
banks and nonbanking companies
owned by the bank holding company,
including the companies listed below.
The public portions of the
applications listed below, as well as
other related filings required by the
Board, if any, are available for
immediate inspection at the Federal
Reserve Bank(s) indicated below and at
the offices of the Board of Governors.
This information may also be obtained
on an expedited basis, upon request, by
contacting the appropriate Federal
Reserve Bank and from the Board’s
Freedom of Information Office at
https://www.federalreserve.gov/foia/
request.htm. Interested persons may
express their views in writing on the
standards enumerated in the BHC Act
(12 U.S.C. 1842(c)). If the proposal also
involves the acquisition of a nonbanking
company, the review also includes
whether the acquisition of the
nonbanking company complies with the
standards in section 4 of the BHC Act
(12 U.S.C. 1843), and interested persons
may express their views in writing on
the standards enumerated in section 4.
Unless otherwise noted, nonbanking
activities will be conducted throughout
the United States.
Comments regarding each of these
applications must be received at the
Reserve Bank indicated or the offices of
the Board of Governors, Ann E.
Misback, Secretary of the Board, 20th
Street and Constitution Avenue NW,
Washington, DC 20551–0001, not later
than June 22, 2022.

VerDate Sep<11>2014

17:33 May 20, 2022

Jkt 256001

A. Federal Reserve Bank of Chicago
(Colette A. Fried, Assistant Vice
President) 230 South LaSalle Street,
Chicago, Illinois 60690–1414:
1. Fidelity Federal Bancorp,
Evansville, Indiana; to become a bank
holding company by acquiring
Community Banks of Shelby County,
Cowden, Illinois, and also to retain
United Fidelity Bank, F.S.B., Evansville,
Indiana, and thereby engage in
operating a savings association pursuant
to section 225.28(b)(4)(ii) of the Board’s
Regulation Y.

[FR Doc. 2022–11011 Filed 5–20–22; 8:45 am]

31237

President) 230 South LaSalle Street,
Chicago, Illinois 60690–1414:
1. Fidelity Federal Bancorp,
Evansville, Indiana; to become a savings
and loan company, following its
conversion to a bank holding company
for a moment in time in connection with
its acquisition of Community Banks of
Shelby County, Cowden, Illinois.
Board of Governors of the Federal Reserve
System.
Michele Taylor Fennell,
Deputy Associate Secretary of the Board.
[FR Doc. 2022–11009 Filed 5–20–22; 8:45 am]
BILLING CODE P

DEPARTMENT OF HEALTH AND
HUMAN SERVICES

BILLING CODE P

FEDERAL RESERVE SYSTEM
Formations of, Acquisitions by, and
Mergers of Savings and Loan Holding
Companies
The companies listed in this notice
have applied to the Board for approval,
pursuant to the Home Owners’ Loan Act
(12 U.S.C. 1461 et seq.) (HOLA),
Regulation LL (12 CFR part 238), and
Regulation MM (12 CFR part 239), and
all other applicable statutes and
regulations to become a savings and
loan holding company and/or to acquire
the assets or the ownership of, control
of, or the power to vote shares of a
savings association.
The public portions of the
applications listed below, as well as
other related filings required by the
Board, if any, are available for
immediate inspection at the Federal
Reserve Bank(s) indicated below and at
the offices of the Board of Governors.
This information may also be obtained
on an expedited basis, upon request, by
contacting the appropriate Federal
Reserve Bank and from the Board’s
Freedom of Information Office at
https://www.federalreserve.gov/foia/
request.htm. Interested persons may
express their views in writing on
whether the proposed transaction
complies with the standards
enumerated in the HOLA (12 U.S.C.
1467a(e)).
Comments regarding each of these
applications must be received at the
Reserve Bank indicated or the offices of
the Board of Governors, Ann E.
Misback, Secretary of the Board, 20th
Street and Constitution Avenue NW,
Washington, DC 20551–0001, not later
than June 22, 2022.
A. Federal Reserve Bank of Chicago
(Colette A. Fried, Assistant Vice

PO 00000

Frm 00031

Fmt 4703

Sfmt 4703

Centers for Disease Control and
Prevention
[60Day–22–0009; Docket No. CDC–2022–
0069]

Proposed Data Collection Submitted
for Public Comment and
Recommendations
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice with comment period.
AGENCY:

The Centers for Disease
Control and Prevention (CDC), as part of
its continuing effort to reduce public
burden and maximize the utility of
government information, invites the
general public and other federal
agencies the opportunity to comment on
a continuing information collection, as
required by the Paperwork Reduction
Act of 1995. This notice invites
comment on a proposed information
collection project titled National Disease
Surveillance Program. This collection
covers the surveillance activities for
four rare disease conditions;
Creutzfeldt-Jakob Disease (CJD), Reye
Syndrome, Kawasaki Syndrome, and
Acute Flaccid Myelitis (AFM).
DATES: CDC must receive written
comments on or before July 22, 2022.
ADDRESSES: You may submit comments,
identified by Docket No. CDC–2022–
0069 by either of the following methods:
• Federal eRulemaking Portal:
www.regulations.gov. Follow the
instructions for submitting comments.
• Mail: Jeffrey M. Zirger, Information
Collection Review Office, Centers for
Disease Control and Prevention, 1600
Clifton Road NE, MS H21–8, Atlanta,
Georgia 30329.
Instructions: All submissions received
must include the agency name and
Docket Number. CDC will post, without
SUMMARY:

E:\FR\FM\23MYN1.SGM

23MYN1

31238

Federal Register / Vol. 87, No. 99 / Monday, May 23, 2022 / Notices

change, all relevant comments to
www.regulations.gov.
Please note: Submit all comments
through the Federal eRulemaking portal
(regulations.gov) or by U.S. mail to the
address listed above.
FOR FURTHER INFORMATION CONTACT: To
request more information on the
proposed project or to obtain a copy of
the information collection plan and
instruments, contact Jeffrey M. Zirger,
Information Collection Review Office,
Centers for Disease Control and
Prevention, 1600 Clifton Road NE, MS
H21–8, Atlanta, Georgia 30329;
Telephone: 404–639–7570; Email: omb@
cdc.gov.
SUPPLEMENTARY INFORMATION: Under the
Paperwork Reduction Act of 1995 (PRA)
(44 U.S.C. 3501–3520), federal agencies
must obtain approval from the Office of
Management and Budget (OMB) for each
collection of information they conduct
or sponsor. In addition, the PRA also
requires federal agencies to provide a
60-day notice in the Federal Register
concerning each proposed collection of
information, including each new
proposed collection, each proposed
extension of existing collection of
information, and each reinstatement of
previously approved information
collection before submitting the
collection to the OMB for approval. To
comply with this requirement, we are
publishing this notice of a proposed
data collection as described below.
The OMB is particularly interested in
comments that will help:
1. Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including

to translate facts about analysis of
morbidity and mortality statistics on
communicable diseases and through
field investigations. It was soon
recognized that control measures (such
as the DDT spraying for malaria) did not
alleviate the threat of disease
reintroduction. In 1950, the Malaria
Surveillance Program began and in
1952, the National Surveillance Program
started. Both programs were based on
the premise that diseases cannot be
diagnosed, prevented, or controlled
until existing knowledge is expanded
and new ideas developed and
implemented. The original scope of the
National Surveillance Program included
the study of malaria, murine typhus,
smallpox, psittacosis, diphtheria,
leprosy, and sylvatic plague. Over the
years, the mandate of CDC has
broadened in preventive health
activities and the surveillance systems
maintained have expanded.
The National Disease Surveillance
Program is authorized under the Public
Health Service Act, Section 301 and 306
(42 U.S.C. 241 and 242K). This
information collection activity covers
surveillance activities for four, rare
diseases: (1) Creutzfeldt-Jakob Disease
(CJD), (2) Reye Syndrome, (3) Kawasaki
Syndrome, and (4) Acute Flaccid
Myelitis. Since the previous approval of
0920–0009, changes are being requested
only to the Acute Flaccid Myelitis form.
The total estimated burden requested by
CDC has been reduced to 98, down 69
hours from the previous total of 167,
and is adjusted to match actual,
experienced burden more closely. There
is no cost to respondents other than the
time to participate.

whether the information will have
practical utility;
2. Evaluate the accuracy of the
agency’s estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
3. Enhance the quality, utility, and
clarity of the information to be
collected; and
4. Minimize the burden of the
collection of information on those who
are to respond, including through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submissions
of responses; and
5. Assess information collection costs.
Proposed Project
National Disease Surveillance
Program (OMB Control No. 0920–0009,
Exp. 8/31/2022)—Revision—National
Center for Emerging and Zoonotic
Infectious Diseases (NCEZID), Centers
for Disease Control and Prevention
(CDC).
Background and Brief Description
Surveillance of the incidence and
distribution of disease has been an
important function of the U.S. Public
Health Service (PHS) since an 1878 Act
of Congress authorized the PHS to
collect morbidity reports. After the
Malaria Control in War Areas Program
had fulfilled its original 1942 objective
of reducing malaria transmission, its
basic tenets were carried forward and
broadened by the formation of the
Communicable Disease Center (CDC) in
1946. CDC was conceived of as a wellequipped, broadly staffed agency used

lotter on DSK11XQN23PROD with NOTICES1

ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents

Average
burden per
response
(in hours)

Number of
responses per
respondent

Total burden
(in hours)

Type of respondents

Form name

Epidemiologist ...................................

CJD ..................................................
Kawasaki Syndrome ........................
Reye Syndrome1 .............................
Acute Flaccid Myelitis ......................

10
20
1
100

2
2
1
4

20/60
15/60
20/60
12/60

7
10
1
80

Total ...........................................

...........................................................

........................

........................

........................

98

Jeffrey M. Zirger,
Lead, Information Collection Review Office,
Office of Scientific Integrity, Office of Science,
Centers for Disease Control and Prevention.
[FR Doc. 2022–10991 Filed 5–20–22; 8:45 am]
BILLING CODE 4163–18–P

VerDate Sep<11>2014

17:33 May 20, 2022

Jkt 256001

PO 00000

Frm 00032

Fmt 4703

Sfmt 9990

E:\FR\FM\23MYN1.SGM

23MYN1


File Typeapplication/pdf
File Modified2022-05-23
File Created2022-05-23

© 2024 OMB.report | Privacy Policy